Trial intelligence / Profile preview

Sitagliptin for Glucose Metabolism in Renal Transplant Recipients

NCT00740363Phase 4Completed

Sponsor
University of Oslo School of Pharmacy
Start
Sep 2008
Primary completion
Jun 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of sitagliptin in post-transplant diabetes mellitus (PTDM), sponsored by University of Oslo School of Pharmacy. Started Sep 2008; status: completed.

02

Drugs

sitagliptin
03

Conditions

post-transplant diabetes mellitus (PTDM)

Beyond the preview

Go deeper on NCT00740363.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00740363.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call